DE1905353C3 - 2-Benzylimidazolinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen - Google Patents

2-Benzylimidazolinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen

Info

Publication number
DE1905353C3
DE1905353C3 DE1905353A DE1905353A DE1905353C3 DE 1905353 C3 DE1905353 C3 DE 1905353C3 DE 1905353 A DE1905353 A DE 1905353A DE 1905353 A DE1905353 A DE 1905353A DE 1905353 C3 DE1905353 C3 DE 1905353C3
Authority
DE
Germany
Prior art keywords
compounds
pharmaceutical preparations
derivatives
compound
benzylimidazoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1905353A
Other languages
German (de)
English (en)
Other versions
DE1905353B2 (de
DE1905353A1 (de
Inventor
Lewis A. Madison N.J. Walter (V.St.A.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scherico Ltd
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherico Ltd filed Critical Scherico Ltd
Publication of DE1905353A1 publication Critical patent/DE1905353A1/de
Publication of DE1905353B2 publication Critical patent/DE1905353B2/de
Application granted granted Critical
Publication of DE1905353C3 publication Critical patent/DE1905353C3/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Float Valves (AREA)
  • Self-Closing Valves And Venting Or Aerating Valves (AREA)
DE1905353A 1968-02-09 1969-02-04 2-Benzylimidazolinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen Expired DE1905353C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70426368A 1968-02-09 1968-02-09

Publications (3)

Publication Number Publication Date
DE1905353A1 DE1905353A1 (de) 1969-09-04
DE1905353B2 DE1905353B2 (de) 1978-12-21
DE1905353C3 true DE1905353C3 (de) 1979-08-30

Family

ID=24828765

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1905353A Expired DE1905353C3 (de) 1968-02-09 1969-02-04 2-Benzylimidazolinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen

Country Status (18)

Country Link
JP (1) JPS5114514B1 (US20050065096A1-20050324-C00034.png)
AT (2) AT295520B (US20050065096A1-20050324-C00034.png)
BE (1) BE727951A (US20050065096A1-20050324-C00034.png)
BR (1) BR6906150D0 (US20050065096A1-20050324-C00034.png)
CA (1) CA941829A (US20050065096A1-20050324-C00034.png)
CH (1) CH515254A (US20050065096A1-20050324-C00034.png)
CS (2) CS154613B2 (US20050065096A1-20050324-C00034.png)
DE (1) DE1905353C3 (US20050065096A1-20050324-C00034.png)
ES (1) ES363246A0 (US20050065096A1-20050324-C00034.png)
FR (1) FR2001655A1 (US20050065096A1-20050324-C00034.png)
GB (1) GB1259005A (US20050065096A1-20050324-C00034.png)
IE (1) IE33387B1 (US20050065096A1-20050324-C00034.png)
IL (1) IL31555A (US20050065096A1-20050324-C00034.png)
LU (1) LU57890A1 (US20050065096A1-20050324-C00034.png)
NL (1) NL6901741A (US20050065096A1-20050324-C00034.png)
NO (1) NO126228B (US20050065096A1-20050324-C00034.png)
SE (1) SE372946B (US20050065096A1-20050324-C00034.png)
SU (1) SU365883A3 (US20050065096A1-20050324-C00034.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965112A (en) * 1971-01-11 1976-06-22 John Wyeth & Brother Limited Imidazoline derivatives
JPS5329010A (en) * 1976-08-30 1978-03-17 Gen Res Electronics Inc Cb transceiver with broadcasting band radio receiver
JPS53137721U (US20050065096A1-20050324-C00034.png) * 1977-04-07 1978-10-31
JPS5861552U (ja) * 1981-10-19 1983-04-25 ソニー株式会社 受信機
JPS59143431A (ja) * 1983-02-03 1984-08-17 Sony Corp 無線機
GB2351082A (en) * 1999-06-18 2000-12-20 Lilly Forschung Gmbh Synthesis of Cyclic Substituted Amidines
FR2846328B1 (fr) * 2002-10-23 2004-12-10 Servier Lab Nouveaux derives de l'imidazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
AT294819B (de) 1971-12-10
NO126228B (US20050065096A1-20050324-C00034.png) 1973-01-08
IL31555A0 (en) 1969-04-30
FR2001655A1 (US20050065096A1-20050324-C00034.png) 1969-09-26
AT295520B (de) 1972-01-10
CS154614B2 (US20050065096A1-20050324-C00034.png) 1974-04-30
BE727951A (US20050065096A1-20050324-C00034.png) 1969-08-05
CH515254A (de) 1971-11-15
GB1259005A (US20050065096A1-20050324-C00034.png) 1972-01-05
CA941829A (en) 1974-02-12
DE1905353B2 (de) 1978-12-21
ES363246A0 (es) 1971-01-16
SE372946B (US20050065096A1-20050324-C00034.png) 1975-01-20
BR6906150D0 (pt) 1973-04-12
CS154613B2 (US20050065096A1-20050324-C00034.png) 1974-04-30
NL6901741A (US20050065096A1-20050324-C00034.png) 1969-08-12
IE33387L (en) 1969-08-09
SU365883A3 (US20050065096A1-20050324-C00034.png) 1973-01-08
IL31555A (en) 1972-10-29
DE1905353A1 (de) 1969-09-04
LU57890A1 (US20050065096A1-20050324-C00034.png) 1969-05-04
IE33387B1 (en) 1974-06-12
JPS5114514B1 (US20050065096A1-20050324-C00034.png) 1976-05-10

Similar Documents

Publication Publication Date Title
DE2203373C3 (de) Neue 2- [(2- Alkylbenzofuran-3-yl)-methyl] -A2 -imidazoline
DE2634288B2 (US20050065096A1-20050324-C00034.png)
DE2500110A1 (de) 3-aryloxy-3-phenylpropylamine und verfahren zu ihrer herstellung
DE2047658A1 (US20050065096A1-20050324-C00034.png)
DE1905353C3 (de) 2-Benzylimidazolinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen
DE2029299B2 (de) Neue Aminophenylamidine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE3233424A1 (de) Isochinolinderivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
DD151408A5 (de) Verfahren zur herstellung neuer pharmazeutisch aktiver phenylpiperazinderivate
DE2412520C2 (de) Tricyclische Verbindungen, Verfahren zu deren Herstellung und diese enthaltende Präparate
DE2366237C2 (de) 4-[2-(2-Methoxynicotinamido)äthyl]-1-piperidinsulfonamid
DE3305495A1 (de) Piperazin- und homopiperazinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DE1933158A1 (de) Sulfaminsaeureamide und deren Alkalisalze sowie Verfahren zu ihrer Herstellung
DE1695882C3 (de) 2-Pyridy!methylamine und Verfahren zu ihrer Herstellung
DE2462966C2 (de) Derivate des 3-Amino-4-acetyl-5-methylpyrrols und diese enthaltende pharmazeutische Zubereitungen
DE2609574C3 (de) 1 -^-Fluor-S-trifluormethylthiophenyD-piperazin, dessen Salze, Verfahren zu dessen Herstellung und Arzneimittel
DE3876546T2 (de) Ethanon-oxime.
DE3012123A1 (de) Pharmazeutisches mittel auf der basis von 1,1,3,5-substituierten biuretverbindungen
DE1470002A1 (de) 5,6-Dihydromorphanthridinderivate
DE2833892A1 (de) 12h-dibenzo eckige klammer auf d,g eckige klammer zu eckige klammer auf 1,3,6 eckige klammer zu dioxazocinderivate, solche enthaltende arzneimittel und verfahren zur herstellung derselben
DE2166270B2 (de) Nicotinoylaminoäthansulfonyl-2amino-thiazol
CH634828A5 (de) Verfahren zur herstellung neuer oximaetherverbindungen.
DE1620373A1 (de) Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
DE2102246C3 (US20050065096A1-20050324-C00034.png)
AT295516B (de) Verfahren zur Herstellung neuer cyclischer Amidine und ihrer Salze
DE1643265C3 (de) Kernsubstituierte 2-Aminomethylbenzhydrole, Verfahren zu deren Herstellung und Arzneimittel auf der Basis dieser Verbindungen

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
EHJ Ceased/non-payment of the annual fee